Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market

Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market (Therapy Type: Targeted Therapy, Immunotherapy and Chemotherapy; Drug Class: Vascular Endothelial Growth Factor (VEGF) Inhibitors, KRAS Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Anaplastic lymphoma kinase (ALK) Inhibitors, ROS1 Inhibitors, BRAF Inhibitors, MET Inhibitors and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025–2035